• Original NDA for implantable intraocular drug delivery system for the sustained release of chemotherapeutic agent for prostate cancer
  • Original NDA and EMEA submissions for sustained release of ganciclovir in the treatment of cytomegalovirus in AIDS patients
  • Original NDA for Isoprinosine (inosine pranobex) in treatment of HSV-I and HSV-2 and treatment of AIDS-related Complex (ARC)